期刊文献+

MLPA在常染色体显性遗传多囊肾病基因诊断中的应用 被引量:3

Application of MLPA in gene diagnosis of autosomal dominant polycystic kidney disease
下载PDF
导出
摘要 目的探讨多重连接探针扩增技术(MLPA)在常染色体显性遗传多囊肾病(ADPKD)基因诊断中的应用。方法采用MLPA对20例ADPKD患者的PKD1基因和PKD2基因进行检测。MLPA检测结果显示单一外显子扩增或疑似扩增者采用RT-PCR检测验证;MLPA检测结果显示单一外显子缺失或疑似缺失者采用PCR检测验证,存在扩增产物者进行测序验证。结果 MLPA检测显示:1例患者单一外显子缺失(PKD1 Exon40),5例单一外显子疑似缺失(PKD1 Exon1、PKD1 Exon25、PKD2 Exon8、PKD2 Exon8、PKD1 Exon25),3例单一外显子疑似扩增(PKD1 Exon6、PKD1 Exon7、PKD1 Exon7)。经RT-PCR检测验证,1例患者单一外显子扩增(PKD1 Exon6);经PCR检测与测序验证,1例患者单一外显子错义突变(PKD1 Exon40),1例单一外显子缺失(PKD2 Exon8)。结论 MLPA为ADPKD的基因诊断提供了一种新的方法。 Objective To investigate the application of multiplex ligation-dependent probe amplification(MLPA) in the gene diagnosis of autosomal dominant polycystic kidney disease(ADPKD). Methods MLPA was employed to detect the PKD1 gene and PKD2 gene in 20 patients with ADPKD.Verification with RT-PCR was performed for those with single exon duplication or suspected duplication detected by MLPA.Those with single exon deletion or suspected deletion detected by MLPA were verified with PCR,and sequencing analysis was conducted in those with amplification products. Results One patient with single exon deletion(PKD1 Exon40),5 patients with single exon suspected deletion(PKD1 Exon1,PKD1 Exon25,PKD2 Exon8,PKD2 Exon8 and PKD1 Exon25) and 3 patients with single exon suspected duplication(PKD1 Exon6,PKD1 Exon7 and PKD1 Exon7) were detected by MLPA.One patient with single exon duplication(PKD1 Exon6) was verified by RT-PCR,and one patient with single exon missense mutation(PKD1 Exon40) and one patient with single exon deletion(PKD2 Exon8) were verified by PCR and sequencing analysis. Conclusion MLPA may serve as a new method for gene diagnosis of ADPKD.
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2011年第7期957-961,共5页 Journal of Shanghai Jiao tong University:Medical Science
基金 上海交通大学医学院附属新华医院院基金(09YJ02)~~
关键词 常染色体显性遗传多囊肾病 基因突变 多重连接探针扩增技术 autosomal dominant polycystic kidney disease gene mutation multiplex ligation-dependent probe amplification
  • 相关文献

参考文献11

  • 1张树忠,张宇红,张殿勇,梅长林.应用变性高效液相色谱技术检测汉族人Ⅰ型多囊肾致病基因突变[J].中华医学遗传学杂志,2006,23(3):283-288. 被引量:10
  • 2梅长林.常染色体显性遗传性多囊肾病研究的热点问题[J].第二军医大学学报,2003,24(1):1-4. 被引量:23
  • 3张维莉,易建中,梅长林.遗传标记RFLP、STR、SNP在常染色体显性遗传性多囊肾病基因连锁分析中的应用[J].第二军医大学学报,2002,23(8):908-910. 被引量:9
  • 4Li J,Yu C,Tao Y,et al.Putative mutation of PKD1 gene responsi-ble for autosomal dominant polycystic kidney disease in a Chinesefamily. International Journal of Urology . 2011
  • 5The European Polycystic Kidney Disease Consortiam.The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16. Cell . 1994
  • 6Ong AC,Harris P C.Molecular pathogenesis of ADPKD:the polycystin complex gets complex. Kidney International . 2005
  • 7Peters DJ,Ariyurek Y,van Dijk M,et al.Mutation detection for exons 2 to 10 of the polycystic kidney disease 1 (PKD1)—gene by DGGE. EurJ Hum Genet . 2001
  • 8Inoue S,Inoue K,Utosunomiya M,et al.Mutation analysis in PKD1 of Japanese autosomal polycystic kidney disease patients. Human Mutation . 2002
  • 9Kozlowski P,Bissler J,Pei Y,et al.Analysis of PKD1 for genomic deletion by multiplex ligation-dependent probe assay:absence of hot spots. Genomics . 2008
  • 10Schouten JP,McElgunn CJ,Waaijer R,et al.Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Research . 2002

二级参考文献28

  • 1吴柏林,朱建中.变性高效液相色谱基因扫描技术在人类疾病基因诊断中的应用[J].中华医学遗传学杂志,2004,21(5):530-535. 被引量:5
  • 2Zhang S,Mei C,Zhang D,Dai B,Tang B,Sun T,Zhao H,Zhou Y,Li L,Wu Y,Wang W,Shen X,Song J.Mutation analysis of autosomal dominant polycystic kidney disease genes in Han Chinese[J].第二军医大学学报,2005,26(8):858-858. 被引量:6
  • 3张树忠,张宇红,张殿勇,梅长林.应用变性高效液相色谱技术检测汉族人Ⅰ型多囊肾致病基因突变[J].中华医学遗传学杂志,2006,23(3):283-288. 被引量:10
  • 4Ricker JL,Gattone VHII,Calvet JP,et al.Development of autosomal recessive polycystic kidney disease in BALB/c-cpk/cpk mice[J].J Am Soc Nephrol,2000,11(8):1837-1847.
  • 5Richards WG,Sweeney WE,Yoder BK,et al.Epidermal growth factor receptor activity mediates renal cyst formation in polycystic kidney disease[J].J Clin Invest,1998,101(7):935-939.
  • 6Dell KM,Nemo R,Sweeney WE,et al.A novel inhibitor of tumor necrosis factor-α converting enzyme ameliorate polycystic kidney disease[J].Kidney Int,2001,60(7):1240-1248.
  • 7Woo D,Tabancay AJ,Wang C.Microtubule active taxanes inhibit polycystic kidney disease progression in cpk mouse[J].Kidney Int,1997,51(11):1613-1618.
  • 8Parnell SC,Magenheimer BS,Maser RL,et al.The polycystic kidney disease-1 protein,polycystin-1,binds and activates heterotrimeric G-protein in vitro[J].Biochem Biophys Res Commun,1998,251(2):625-631.
  • 9Vandorpe DH,Chernova MN,Jiang L,et al.The cytoplasmic C-terminal fragment of polycystin-1 regulates a Ca2+-permeable cation channel[J].J Biol Chem,2001,276(10):4093-4101.
  • 10Roth KE,Rieder CL,Bowser SS.Flexible-substratum technique for viewing cells from the side:some in vivo properties of primary (9+0) cilia in cultured kidney epithelia[J].J Cell Sci,1988,89(3):457-466.

共引文献35

同被引文献15

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部